Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Post by SouthernTierTomon May 07, 2022 8:36pm
293 Views
Post# 34664942

IR comes in so many forms ; - ) ...

IR comes in so many forms ; - ) ...I'm just glad we had MODs available so that SOFA could be shelved for a decade + or so. during our development phase.

Didn't David's partner develop MODSs? ...it is a small world id-ent it?  Who might be in charge of this TIGRIS deal?  Surely not some anonymous consultant with no available or recognizable ties to the company?  Another good question for the "BullBoared Help"...they do appear a little dunse when it comes to company knowledge ; - )

I'm more intetested in the Phase 2 Eupas trial that we managed to avoid as a ticker symbol and diagnostic provider.

Shouldn't the design captain of the phase 3 have followed the phase 2 blue-print?  That must bet water from another river sailed under another bridge but banked for future reference.  

I wonder if the knewest effory here on the rogue social media network is connect to the last act of desperation when stories of Birch Hill selling were strategically circulated and  directed out just prior to the move to 15 cents to fortunately make all swell with the 32 cent offering to special people and special AMericans...we are special aren''t oui.

Focua on the FAILED phase 3 and the specialtral interview the morning of October 3rd 2016, whilst our investment "appeared to implode" with a 1 penny bid / ask despite the Dialco development and now of course the incredible "Deep Data Dive" and the pending recognition of the EAA to launch a "potential" Canadien "Precision Medicine Campaign?  I'll bet "Arsistoltle" stands at the ready... wink wink  ; - )

I would mostly read and understand this..IMHO, it is indeed important;

So let's get this straight.... now the FAILED phase 3 Euphrates trial formulates a 75% weighting in a FDA phase 3B confirmatory trial where 2 of every 3 patients in a critical care setting with a primary endpoint of 28 day mortality ACTUALLY get the FAILED device from the phase 3. REALLY?  What is next, do we spin $5M USD from a major pharma like say, Baxter into a liability and print 100M shares with the precision of an insider based "personalized investment program" When does 60 Minutes do a full hour on this one?  Nevermind 15 minutes on experimental Exthera, this has waaay more cache baby!... it has cache up the ying-yang, where the ying-yang is the retail invester.

There is a reason you were told not to put money in your mouth as a kid...it is very dirty...especially the BIG bills..cuz people like to keep them on the outside so to look prosperous.
<< Previous
Bullboard Posts
Next >>